Latest News
March 23, 2019
Study explores third-line trabectedin plus PLD for BRCA1/2 ovarian cancer
March 23, 2019
MDedge Hematology and Oncology
March 22, 2019
Combo shows promise for endometrial, ovarian cancers
March 22, 2019
MDedge Hematology and Oncology
March 22, 2019
Rituximab boosts survival in primary CNS lymphoma
March 22, 2019
MDedge Hematology and Oncology
March 22, 2019
FDA chief calls for stricter scrutiny of electronic health records
March 22, 2019
MDedge Hematology and Oncology
Hem-Onc Board Review
Clinical Reviews
February 14, 2019
Chronic Myeloid Leukemia: A Review of TKI Therapy
February 14, 2019
MDedge Hematology and Oncology
February 6, 2019
Chronic Myeloid Leukemia: Evaluation and Diagnosis
February 6, 2019
MDedge Hematology and Oncology
January 18, 2019
Aplastic Anemia: Evaluation and Diagnosis
January 18, 2019
MDedge Hematology and Oncology
October 1, 2018
Management of Metastatic Gastric Cancer
October 1, 2018
MDedge Hematology and Oncology
Conference Coverage
March 23, 2019
Study explores third-line trabectedin plus PLD for BRCA1/2 ovarian cancer
March 23, 2019
MDedge Hematology and Oncology
March 22, 2019
Combo shows promise for endometrial, ovarian cancers
March 22, 2019
MDedge Hematology and Oncology
March 22, 2019
Study: Racial disparities in gyn-onc trial enrollment persist
March 22, 2019
MDedge Hematology and Oncology
Business of Medicine
March 22, 2019
FDA chief calls for stricter scrutiny of electronic health records
March 22, 2019
MDedge Hematology and Oncology
March 19, 2019
Will patient rewards for lower-cost choices impact physicians?
March 19, 2019
MDedge Hematology and Oncology
March 13, 2019
Prior authorization an increasing burden
March 13, 2019
MDedge Hematology and Oncology
FDA/CDC
March 21, 2019
FDA examines changing donation policies for men who have sex with men
March 21, 2019
MDedge Hematology and Oncology
March 8, 2019
FDA approves Tecentriq plus Abraxane in breast cancer
March 8, 2019
MDedge Hematology and Oncology
March 2, 2019
Priority review granted to lenalidomide for FL, MZL
March 2, 2019
MDedge Hematology and Oncology
February 26, 2019
Selinexor hits FDA stumbling block
February 26, 2019
MDedge Hematology and Oncology
Perspectives
February 20, 2019
Diagnostic metal rod, eyeball extramission, fungal foot fetish
February 20, 2019
MDedge Hematology and Oncology
Hematology
March 22, 2019
FDA halts enrollment in trial of venetoclax for multiple myeloma
March 22, 2019
MDedge Hematology and Oncology
March 19, 2019
AUGUSTUS: Dual surpasses triple therapy when AFib patients have PCI or ACS
March 19, 2019
MDedge Hematology and Oncology
March 18, 2019
Andexanet alfa effectively reverses factor Xa inhibition
March 18, 2019
MDedge Hematology and Oncology
March 15, 2019
Repeat VTE risk heightened in HIV patients
March 15, 2019
MDedge Hematology and Oncology
Follicular Lymphoma
March 21, 2019
High survival in relapsed FL after primary radiotherapy
March 21, 2019
MDedge Hematology and Oncology
February 11, 2019
Anthracyclines, bendamustine are options for grade 3A follicular lymphoma
February 11, 2019
MDedge Hematology and Oncology
February 11, 2019
Daratumumab disappoints in non-Hodgkin lymphoma trial
February 11, 2019
MDedge Hematology and Oncology
February 10, 2019
BCL expression intensity key in distinguishing FL lesions
February 10, 2019
MDedge Hematology and Oncology
January 16, 2019
Study supports need for less toxic therapies in FL
January 16, 2019
MDedge Hematology and Oncology
Breast Cancer
March 18, 2019
Breast cancer survivors offer realistic strategies for easing cost burden
March 18, 2019
MDedge Hematology and Oncology
March 15, 2019
Combo shows promise in HER2-positive breast cancer with brain mets
March 15, 2019
MDedge Hematology and Oncology
March 12, 2019
FDA approves another trastuzumab biosimilar for HER2-positive breast cancer, gastric cancer
March 12, 2019
MDedge Hematology and Oncology
March 12, 2019
Novel immunostimulant combo shows early efficacy
March 12, 2019
MDedge Hematology and Oncology
March 8, 2019
FDA approves Tecentriq plus Abraxane in breast cancer
March 8, 2019
MDedge Hematology and Oncology